CWBR

CohBar, Inc. [CWBR] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CWBR Stock Summary

In the News

11:44 29 Mar 2024 CWBR

Why Is CohBar (CWBR) Stock Up 130% Today?

CohBar (NASDAQ: CWBR ) stock is soaring higher on Tuesday after the company announced a planned merger with Morphogenesis . CohBar and Morphogenesis are planning for an all-stock merger that will see the two combine to create a new company named “TuHURA Biosciences, Inc.” This company will continue to trade its shares on The Nasdaq Capital Market.

09:00 29 Mar 2024 CWBR

CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022

Company to host conference call and webcast at 5:00 p.m. ET Company to host conference call and webcast at 5:00 p.m. ET

01:33 29 Mar 2024 CWBR

Cohbar Inc. (CWBR) Upgraded to Strong Buy: What Does It Mean for the Stock?

Cohbar Inc. (CWBR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

06:21 29 Mar 2024 CWBR

7 Nasdaq Stocks to Sell Before They Die

As is typical of a bear market, the Nasdaq has led the other major indices lower over the past year. The tech-heavy index is down 28% over the past 12 months compared with a 17% decline in the S&P 500.

08:35 29 Mar 2024 CWBR

CohBar (CWBR) Stock: 1-For-30 Reverse Split Goes Into Effect

A 1-for-30 reverse split of CohBar (CWBR) stock has gone into effect today. These are the details.

09:00 29 Mar 2024 CWBR

CohBar to Present at H.C. Wainwright 24th Annual Global Investment Conference

MENLO PARK, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company exploiting the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases, announced today that its Chief Executive Officer, Dr. Joseph Sarret, will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference, being held September 12 - 14, 2022.

08:11 29 Mar 2024 CWBR

CohBar, Inc. (CWBR) CEO Joe Sarret on Q2 2022 Results - Earnings Call Transcript

CohBar, Inc. (NASDAQ:CWBR ) Q2 2022 Earnings Conference Call August 15, 2022 5:00 PM ET Company Participants Jordyn Tarazi - Director of IR Joe Sarret - CEO Jeff Biunno - CFO Nick Vlahakis - Acting CMO Kent Grindstaff - SVP, Research Conference Call Participants Kumar Raja - Brookline Capital Markets Operator Good afternoon. My name is Ryan, and I will be your conference operator for today.

09:00 29 Mar 2024 CWBR

CohBar to Announce 2022 Second Quarter Financial Results and Provide Business Update on August 15, 2022

Company to host conference call and webcast at 5:00 p.m. ET Company to host conference call and webcast at 5:00 p.m. ET

04:02 29 Mar 2024 CWBR

CohBar to Present at the H.C. Wainwright Global Investment Conference

MENLO PARK, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases, announced today its virtual participation in the 2022 H.C. Wainwright Global Investment Conference.

09:20 29 Mar 2024 CWBR

CohBar Inc. (CWBR) CEO Joe Sarret on Q1 2022 Results - Earnings Call Transcript

CohBar Inc. (NASDAQ:CWBR ) Q1 2022 Results Conference Call May 16, 2022 5:00 PM ET Company Participants Joe Sarret - CEO Jeff Biunno - CFO Nick Vlahakis - Acting CMO Kent Grindstaff - SVP, Research Conference Call Participants Kristen Kluska - Cantor Fitzgerald Kumar Raja - Brookline Capital Markets Operator Good afternoon. My name is John, and I will be your conference operator today.

CWBR Financial details

Company Rating
Neutral
Market Cap
2.21M
Income
-12.35M
Revenue
0
Book val./share
3.27
Cash/share
4.24
Dividend
-
Dividend %
-
Employees
9
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
-0.17
Forward P/E
-0.08
PEG
0.04
P/S
-
P/B
0.23
P/C
0.21
P/FCF
-0.27
Quick Ratio
4.12
Current Ratio
4.16
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-4.26
EPS next Y
-10.5
EPS next Q
1.58
EPS this Y
-40.49%
EPS next Y
146.48%
EPS next 5Y
146.48%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
112.86%
-
-
-
-
SMA20
-1.23%
SMA50
3.9%
SMA100
-54.8%
Inst Own
5.94%
Inst Trans
46.06%
ROA
-99%
ROE
-87%
ROC
-1.38%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
2.91M
Shs Float
2.48M
-
-
-
-
Target Price
-
52W Range
0.58-6.9
52W High
-
52W Low
-
RSI
54.39
Rel Volume
0.17
Avg Volume
3.42K
Volume
593
Perf Week
15.73%
Perf Month
15.8%
Perf Quarter
-68.57%
Perf Half Y
-69.7%
-
-
-
-
Beta
1.527
-
-
Volatility
0.09%, 0.07%
Prev Close
-11.99%
Price
0.8801
Change
-11.98%

CWBR Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-11.42-9.56-8.99-6.94-4.13
Operating cash flow per share
-7.37-7.08-6.01-6.51-3.6
Free cash flow per share
-7.68-7.19-6.03-6.51-3.6
Cash per share
16.138.812.9211.825.43
Book value per share
13.065.711.3611.545.29
Tangible book value per share
13.055.6911.3511.535.28
Share holders equity per share
13.065.711.3611.545.29
Interest debt per share
2.532.880.930.20
Market cap
128.29M68.5M65.41M23.31M4.93M
Enterprise value
125.48M59.29M63.21M18.68M-1M
P/E ratio
-8.17-5.02-4.47-1.51-0.41
Price to sales ratio
00000
POCF ratio
-12.66-6.78-6.69-1.61-0.47
PFCF ratio
-12.16-6.68-6.67-1.61-0.47
P/B Ratio
7.148.423.540.910.32
PTB ratio
7.148.423.540.910.32
EV to sales
00000
Enterprise value over EBITDA
-8.28-4.82-4.09-1.210.08
EV to operating cash flow
-12.39-5.87-6.46-1.290.1
EV to free cash flow
-11.89-5.78-6.45-1.290.1
Earnings yield
-0.12-0.2-0.22-0.66-2.43
Free cash flow yield
-0.08-0.15-0.15-0.62-2.12
Debt to equity
0.160.410.040.010
Debt to assets
0.130.250.030.010
Net debt to EBITDA
0.190.750.140.30.49
Current ratio
10.386.346.9815.9615.69
Interest coverage
-27.52-16.73-16.18-210.5-1.21K
Income quality
0.650.770.60.930.86
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
0.040.01000
Capex to revenue
00000
Capex to depreciation
-5.35-1.01-0.17-0.060
Stock based compensation to revenue
00000
Graham number
57.9435.0347.9542.4422.17
ROIC
-0.75-1.15-0.62-0.59-0.79
Return on tangible assets
-0.68-1.01-0.67-0.56-0.73
Graham Net
12.445.0210.816.295.08
Working capital
20.28M10.89M18.36M25.26M15.18M
Tangible asset value
17.94M8.12M18.47M25.59M15.31M
Net current asset value
17.36M7.53M18.01M25.26M15.18M
Invested capital
0.160.410.040.010
Average receivables
00086.75K100.5K
Average payables
817.38K793.76K586.19K549.8K276.05K
Average inventory
000-10.71M-10.71M
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.87-1.68-0.79-0.6-0.78
Capex per share
-0.31-0.1-0.0200

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2022-06-302022-09-302022-12-312023-03-31 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.93-0.8-1.27-0.7-1.49
Operating cash flow per share
-1.18-0.62-0.94-0.56-0.62
Free cash flow per share
-1.18-0.62-0.94-0.56-0.62
Cash per share
6.936.325.434.884.24
Book value per share
7.156.465.294.683.27
Tangible book value per share
7.146.455.284.673.26
Share holders equity per share
7.156.465.294.683.27
Interest debt per share
0.010.030.04-0.050
Market cap
16.52M8.36M4.93M5.17M8.11M
Enterprise value
13.64M4.15M-1M-224.66K1.92M
P/E ratio
-1.53-0.9-0.34-0.64-0.47
Price to sales ratio
00000
POCF ratio
-4.84-4.67-1.81-3.17-4.5
PFCF ratio
-4.84-4.67-1.81-3.17-4.5
P/B Ratio
0.80.450.320.380.85
PTB ratio
0.80.450.320.380.85
EV to sales
00000
Enterprise value over EBITDA
-5.07-1.750.260.11-0.44
EV to operating cash flow
-4-2.320.370.14-1.06
EV to free cash flow
-4-2.320.370.14-1.06
Earnings yield
-0.16-0.28-0.74-0.39-0.53
Free cash flow yield
-0.21-0.21-0.55-0.32-0.22
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
1.071.781.572.561.43
Current ratio
28.4534.8115.6915.944.16
Interest coverage
-146.59-31.31-31.1317.140
Income quality
1.250.750.720.750.42
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
12.2510.7612.278.6110.47
ROIC
-0.13-0.13-0.25-0.16-0.48
Return on tangible assets
-0.13-0.12-0.22-0.14-0.35
Graham Net
6.686.135.084.573.21
Working capital
20.42M18.48M15.18M13.42M9.47M
Tangible asset value
20.69M18.73M15.31M13.49M9.49M
Net current asset value
20.42M18.48M15.18M13.42M9.47M
Invested capital
00000
Average receivables
0013.75K13.75K21.16K
Average payables
474.65K282.96K218.71K356.26K954.08K
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.13-0.12-0.24-0.15-0.46
Capex per share
00000

CWBR Frequently Asked Questions

What is CohBar, Inc. stock symbol ?

CohBar, Inc. is a US stock , located in Menlo park of Ca and trading under the symbol CWBR

What is CohBar, Inc. stock quote today ?

CohBar, Inc. stock price is $0.8801 today.

Is CohBar, Inc. stock public?

Yes, CohBar, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Similar Market Cap